Keywords: GLP-1; glucagon-like peptide-1; GLP-1RA; glucagon-like peptide-1 receptor agonists; DR; diabetic retinopathy; VEGF; vascular endothelial growth facto; DM; diabetes mellitus; Ops; oscillatory potentials; E4; Exenatide-4; GCL; ganglion cell layer; RGC; Reti
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Diabetes; Enfermedad renal crónica; NefropatÃa diabética; Enfermedad renal del diabético; iSGLT2; arGLP1; iDPP4; Diabetes; Chronic kidney disease; Diabetic nephropathy; Diabetic kidney disease; SGLT2-i; GLP-1RA; DPP4-i;
Keywords: A1C; glycated hemoglobin; DPP-4i; dipeptidyl peptidase-4 inhibitor; DURATION-8; Diabetes Therapy Utilization: Researching Changes in A1C, Weight and Other Factors Through Intervention with Exenatide Once Weekly-8; GLP-1; glucagon-like peptide-1; GLP-1RA;
Keywords: T2DM; type 2 diabetes; IR; insulin resistance; HbA1c; glycated hemoglobin A1c; GLUT-4; glucose transporter4; GLP-1; glucagon-like peptide-1; DPP4; dipeptidyl peptidase; eGFR; estimated glomerular filtration rate; HF; heart failure; UKPDS; United Kingdom P
Keywords: GLP-1; GLP-1 receptor agonists; Energy expenditure; Systematic review; AIEE; activity-induced energy expenditure; BM; body mass; BW; body weight; CHF; chronic heart failure; CHO; carbohydrate; CI; confidence interval; DIT; diet-induced thermogenesis; EE;
Keywords: Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Thiazolinediones; Pioglitazone; Dipeptidyl peptidase 4 (DPP-4) inhibitors; Glucagon-like peptide-1 receptor agonists (GLP-1RA); BCAAs; branched-chain amino acids; ARB; angioten
Keywords: BP; blood pressure; FPG; fasting plasma glucose; GLP-1RA; glucagon-like peptide 1 receptor agonist; HbA1c; hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; ITT; intent to treat; LDL-C; low-density lipoprotein cholesterol; LS; least-squares; T2
Keywords: Aβ; amyloid β protein; AD; Alzheimer's disease; AGEs; advanced glycation end products; BSA; bovine serum albumin; CAT; catalase; DM; diabetes mellitus; Ex-4; exendin-4; GLP-1; glucagon-like peptide-1; GLP-1RA; glucagon-like peptide-1 receptor agonist;
GLP-1 receptor agonist liraglutide exerts central action to induce β-cell proliferation through medulla to vagal pathway in mice
Keywords: Glucagon-like peptide-1; Glucose metabolism; Vagus nerve; Liraglutide; Brain stem; Pancreatic β-cell proliferation; AP; Area postrema; ARC; Arcuate nucleus; AChR; Acetylcholine receptor; α-MSH; Alpha-melanocyte-stimulating hormone; BBB; Blood brain barr
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials
Keywords: Glucagon-like peptide-1 (PubChem CID: 16135499); Sitagliptin (PubChem CID: 4369359); Vildagliptin (PubChem CID: 6918537); Saxagliptin (PubChem CID: 11243969); Linagliptin (PubChem CID: 10096344); Alogliptin (PubChem CID: 11450633); AKI; acute kidney injur
Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
Keywords: CV; cardiovascular; EQW; exenatide once weekly; EXSCEL; Exenatide Study of Cardiovascular Event Lowering; GLP-1RA; glucagon-like peptide-1 receptor agonist; MACE; major adverse cardiac events; MI; myocardial infarction;
The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes
Keywords: GLP-1; glucagon like peptide-1; GLP-1RA; glucagon like peptide-1 receptor agonist; FMD; flow mediated dilatation; 8-iso-PGF2α; 8-iso prostaglandin F2α; Type 1 diabetes; GLP-1; Endothelial function; Oxidative stress; Metabolic memory;